Immunogenicity of Biopharmaceuticals: Shaping the Future

Coral Gables Symposium 2012 provides a unique forum for thought leaders to address the principal concerns regarding the immunogenicity of biopharmaceuticals; in their development, regulation, and clinical use.

Scientific Organizing Committee

Dr. Michael Tovey, Chair

Dr. Shalini Gupta, Amgen

Dr. Susan Kirshner, FDA

Dr. Daniel Kramer, Merck Serono

Dr. Robin Thorpe, NIBSC

Who should attend?

Those in academia, industry, regulatory agencies and clinical practice, concerned with scientific, strategic and developmental issues covering immunogenicity assessment of biotherapeutics.

Coral Gable Symposium 2012 provides a unique opportunity to

-participate in informal discussions with thought leaders from academia, industry, regulatory agencies and clinical practice.

-influence future approaches to the major challenges confronting those active in the field.

-enjoy a convivial environment designed to foster the exchange of ideas.

The outcome will be documented in white papers to be submitted for publication in appropriate peer reviewed journals.